|
Volumn 5, Issue 3, 2008, Pages 130-131
|
Why do men who receive finasteride have an increased prevalence of high-grade prostate cancer? Commentary
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FINASTERIDE;
PLACEBO;
CANCER GRADING;
CANCER INHIBITION;
CANCER SIZE;
CANCER SURVIVAL;
CHRONIC DRUG ADMINISTRATION;
CLINICAL TRIAL;
DRUG SAFETY;
GLEASON SCORE;
HUMAN;
PATIENT COUNSELING;
PREVALENCE;
PRIORITY JOURNAL;
PROSTATE BIOPSY;
PROSTATE CANCER;
PROSTATECTOMY;
SHORT SURVEY;
TISSUE DEGENERATION;
|
EID: 40749110617
PISSN: 17434270
EISSN: 17434289
Source Type: Journal
DOI: 10.1038/ncpuro1041 Document Type: Short Survey |
Times cited : (1)
|
References (4)
|